Research
Education
Sign In
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
State Key Laboratory of Respiratory Disease,
Guangzhou Institute of Respiratory Health,
State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health
Wenbin Ding has not added Biography.
If you are Wenbin Ding and would like to personalize this page please email our Author Liaison for assistance.
Pulmonary IFN-γ Causes Lymphocytic Inflammation and Cough Hypersensitivity by Increasing the Number of IFN-γ-Secreting T Lymphocytes.
Allergy, asthma & immunology research Nov, 2022 | Pubmed ID: 36426396
Predictive value of clinical features for anti-reflux therapy response in suspected gastroesophageal reflux-induced chronic cough.
Journal of thoracic disease Apr, 2023 | Pubmed ID: 37197530
Intrapulmonary IFN-γ instillation causes chronic lymphocytic inflammation in the spleen and lung through the CXCR3 pathway.
International immunopharmacology Sep, 2023 | Pubmed ID: 37481849
Sputum Transcriptomics Reveals FCN1+ Macrophage Activation in Mild Eosinophilic Asthma Compared to Non-Asthmatic Eosinophilic Bronchitis.
Allergy, asthma & immunology research Jan, 2024 | Pubmed ID: 38262391
AMG487 alleviates influenza A (H1N1) virus-induced pulmonary inflammation through decreasing IFN-γ-producing lymphocytes and IFN-γ concentrations.
British journal of pharmacology Jul, 2024 | Pubmed ID: 38500396
The First Affiliated Hospital of Guangzhou Medical University
Wenbin Ding1,
Mengxi Luo1,
Zhengyang Lin1,
Zheng Deng1,2
1State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University,
2, Guangzhou National Laboratory
Privacy
Terms of Use
Policies
Contact Us
Recommend to library
JoVE NEWSLETTERS
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Authors
Librarians
Access
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved